Targeted synthesis via the structure-activity relationship: Biological evaluation of new 1,2,3-triazoles monoterpene as antitumor agents
作者:Ezaddine Irrou、Younesse Ait Elmachkouri、Soukaina El Haddad、Yassine Riadi、Ali Oubella、Aziz Auhmani、Md Tabish Rehman、Mohamed F AlAjmi、Hamid Morjani、Nada Kheira Sebbar、Moulay Youssef Ait Itto、Mohamed Labd Taha
DOI:10.1016/j.molstruc.2024.138025
日期:2024.7
A novel series of thiazolidinone based 1,2,3-triazole derivatives were designed, synthesized, and evaluated for their cytotoxic activity against four human cancer cell lines, including fibrosarcoma (HT-1080), lung carcinoma (A-549), and breast carcinoma (MCF-7 and MDA-MB-231). NMR (H and C) and HRMS established the newly synthesized compounds' structural identification and molecular weight. Most synthesized
设计、合成了一系列基于噻唑烷酮的新型 1,2,3-三唑衍生物,并评估了它们对四种人类癌细胞系的细胞毒活性,包括纤维肉瘤 (HT-1080)、肺癌 (A-549) 和乳腺癌癌(MCF-7 和 MDA-MB-231)。 NMR(1H 和 C)和 HRMS 确定了新合成化合物的结构鉴定和分子量。大多数合成的化合物显示出中等的细胞毒活性,IC 值在 20 至 40 μM 之间。此外,杂合化合物对 HT-1080 和 A-549 癌细胞系表现出重要的抑制活性,IC 值为 18 μM。分子对接分析还证实,与阿霉素(对照)相比,化合物对 Bcl-2 蛋白具有更高的结合亲和力。特别地,与其他化合物相比,化合物和Bcl-2具有更高的亲和力。